[144] Critical Metals Corp. SEC Filing

Rhea-AI Filing Summary

Form 144 notice from an insider of Critical Metals Corp. (CRML) proposing the sale of 50,000 shares of common stock through Oppenheimer & Co. Inc. The filing lists an aggregate market value of $813,450.00 and total shares outstanding of 104,912,853. The proposed approximate date of sale is 10/10/2025 on NASDAQ. The securities were acquired as compensation from the issuer with acquisition and payment dates recorded as 10/10/2025. No sales by the filer in the past three months are reported. The filer certifies they do not possess undisclosed material adverse information about the issuer.

Positive

• Clear disclosure of broker, share count, market value, and sale date
• No sales by the filer in the past three months reported

Negative

• Insider sale of 50,000 shares (possible downward pressure on float near sale date)

Insights

Equity Capital Markets Analyst

Insider plans modest sale: 50,000 shares valued at $813,450 on 10/10/2025.

The notice indicates an insider-originated sale using Oppenheimer & Co. for approximately $813,450, representing about 0.048% of reported outstanding shares (50,000 of 104,912,853). Such filings commonly reflect routine liquidity by insiders rather than operational changes.

Key dependencies include the actual execution on 10/10/2025 and whether further filings (Form 4) disclose additional sales or ownership changes; monitor subsequent transaction filings within days after the proposed sale date.

Corporate Governance Specialist

Form 144 documents a rule-based proposed sale; filer affirms no undisclosed material information.

The filing records acquisition as compensation from the issuer on the same date as the proposed sale, and includes the required broker and transaction details. This aligns with Rule 144 procedures for restricted or control securities becoming eligible for public resale.

Watch for accompanying public disclosures or a Form 4 that confirm the sale and update insider holdings; absence of past three-month sales is noted in the filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Oppenheimer & Co Inc 380 Knollwood Street Winston Salem NC 27103	50000	813450.00	104912853	10/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	10/10/2025	compensation	issuer			50000	10/10/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CRML Form 144 disclose?

It discloses a proposed sale of 50,000 common shares valued at $813,450.00 with an approximate sale date of 10/10/2025 via Oppenheimer & Co. Inc.

Who is the broker for the proposed CRML sale?

The broker listed is Oppenheimer & Co. Inc., 380 Knollwood Street, Winston Salem, NC.

How many CRML shares are outstanding per the filing?

The filing states 104,912,853 shares outstanding.

When were the securities acquired that are being sold?

The securities were recorded as acquired as compensation from the issuer on 10/10/2025.

Does the filing report recent sales by the filer?

No. The filing indicates "Nothing to Report" for securities sold during the past three months.